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Abstract
Background: Chromosome 22q11.2 region is highly susceptible to rearrangement, specifically
deletions that give rise to a variety of genomic disorders including velocardiofacial or DiGeorge
syndrome. Individuals with this 22q11 microdeletion syndrome are at a greatly increased risk to
develop schizophrenia.
Methods:  Genotype analysis was carried out on the DNA from a patient with the 22q11
microdeletion using genetic markers and custom primer sets to define the deletion. Bioinformatic
analysis was performed for molecular characterization of the deletion breakpoint sequences in this
patient.
Results: This 22q11 deletion patient was established to have a novel 2.3 Mb deletion with a
proximal breakpoint located between genetic markers RH48663 and RH48348 and a distal
breakpoint between markers D22S1138 and SHGC-145314. Molecular characterization of the
sequences at the breakpoints revealed a 270 bp shared sequence of the breakpoint regions (SSBR)
common to both ends that share >90% sequence similarity to each other and also to short
interspersed nuclear elements/Alu elements.
Conclusion: This Alu sequence like SSBR is commonly in the proximity of all known deletion
breakpoints of 22q11 region and also in the low copy repeat regions (LCRs). This sequence may
represent a preferred sequence in the breakpoint regions or LCRs for intra-chromosomal
homologous recombination mechanisms resulting in common 22q11 deletion.
Background
The 22q11.2 region is a hotspot for rearrangements due to
deletions, duplications and translocations. These rear-
rangements result in altered gene dosage [1] and lead to
congenital malformations including DiGeorge (DGS;
MIM 188400)[2], velocardiofacial (VCFS; MIM
192430)[3], der(22) [4] and cat-eye (MIM 115470) syn-
dromes [5]. The most common of these 22q11.2 microde-
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letion syndromes is the VCFS/DGS, which occurs with an
estimated frequency of 1 in every 4000 live births [6]. It
represents a variety of clinical manifestations including
learning disabilities, characteristics facial appearance, vel-
opharyngeal insufficiency, hypernasal speech, cleft palate
and conotruncal heart defects [3]. A subset of severely
affected patients also have a hypoplastic or absent thymus
gland and hypoparathyroidism with hypocalcaemia [2].
Most clinical features associated with this disorder show
variable expressivity and reduced penetrance [1], however
adults with this syndrome commonly develop major psy-
chiatric illnesses, particularly schizophrenia and bipolar
disorder [7-11]. The vast majority of patients share a com-
mon 3 Mb hemizygous deletion. Except for a few rare
cases, the remaining patients have smaller deletions
nested within the 3 Mb typically deleted region (TDR)
[12].
The molecular nature of the rearrangements responsible
for 22q11 microdeletions are related to the genomic struc-
ture of the 22q11.2 region, which contains long stretches
of repeated sequences clustered together, known as low-
copy repeats (LCRs) of >95% identity [13,14]. These chro-
mosome 22-specific LCRs have been reported at or near
the breakpoints of the 3 Mb TDR affecting the DGS/VCFS
deletion on 22q11.2 [15-20]. They are known to mediate
unequal non-allelic homologous recombination events
and contribute to the rearrangements associated with
genomic disorders [21-23]. Interestingly, not all LCRs of
22q11 appear equally effective in causing microdeletions
and they do differ with respect to some of their sequences.
Further, LCRs contain highly repetitive elements such as
short interspersed nuclear elements (SINEs) and long
interspersed nuclear elements (LINEs). These elements,
particularly SINEs have been implicated in chromosome
rearrangements and disease [24]. Alu elements, part of the
SINE family of transposable elements [24], have also been
established as having a role in modulating the architecture
of the human genome in association with human disor-
ders and in mediating gene rearrangements has been
established [25,26]. It is therefore important to assess the
nature of individual LCRs associated Alu elements in
novel microdeletions.
In this paper we report the result from a case study where
we have characterized the deletion region in a VCFS
patient. We have identified a novel 2.3 Mb deletion in
chromosome 22q11.2 region in the patient. We have also
analyzed the sequences at the two breakpoints for possi-
ble Alu like elements and identified a shared sequence of
the breakpoint regions (SSBR) that may predispose this
region to microdeletions.
Methods
Patient selection
A patient with a 22q11 microdeletion was identified and
gave informed consent to participate in research aimed at
increasing knowledge about the deletion.
Chromosome 22q11 microdeletion analysis
Genomic DNA was extracted from fresh peripheral blood
of the patient using QIAamp DNA maxi kit (QIAgen inc.)
following the manufacturer's instructions. Genotype anal-
ysis within the 22q11 region was conducted to precisely
define the chromosome breakpoints. The DNA sequence
from this region was used to independently confirm the
hemizygousity observed during FISH analysis. It was also
used to establish the exact region involved in the patient
specific deletion through dosage analysis of markers
within the 22q11 region using a total of 40 PCR primer
sets [see Additional file 1]. Eighteen of the primer sets rep-
resented established sequence-tag site (STS) markers [27]
that reside in the 3 Mb TDR. The remaining primer sets
were designed within STS markers found to encompass
novel proximal and distal breakpoint regions (this study).
The patient's marker specific dosage was compared to a
matched control. PCR products were analyzed on a 6%
polyacrylamide gel to confirm expected PCR amplifica-
tion. PCR fragments of interest were then isolated and
purified from the gel and the identity of the fragment was
confirmed by diagnostic restriction enzymes or sequenc-
ing. The PCR conditions for all sets of experiments (P)
were optimized and contained an internal control (N).
PCR product quantitation was carried out in the log phase
at three PCR cycles (usually between 20 to 30 cycles) using
a gel documentation system (Molecular Analyst 1.5, Bio-
Rad Laboratories). A 1N:1P ratio indicated no deletion
and a ratio of 2N:1P indicated a marker deletion in the
patient. All dosage estimates were based on three inde-
pendent PCR reactions. This analysis enabled us to nar-
row down the deletion breakpoint regions while PCR
amplification of the recombined DNA and its sequencing
allowed us to establish the sequence of the patient specific
deleted region.
Analysis and characterization of the 22q11 breakpoints
The sequencing of the breakpoints allowed us to identify
the distal and proximal short sequences involved in any
break and re-joining. The genomic sequence of the 22q11
typically deleted region (22qTDR) from genetic marker
D22S427 to D22S308 was obtained from the Ensembl
human genome database [28]. Repeat sequences were
masked using the RepeatMasker tool [29]. Blastn [30]
analysis of the sequences at the proximal and distal break-
points established a shared sequence between the break-
point regions (SSBR). This SSBR sequence was compared
with both the original and repeat masked 22qTDR
sequence using BLAST analysis where gapped alignmentBMC Medical Genetics 2006, 7:18 http://www.biomedcentral.com/1471-2350/7/18
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was applied with low complexity filter on the query
sequence. The identity cut off for all comparisons were set
to 90% with a minimum length of 200.
Data regarding location, class type, name and any other
pertinent information was also obtained for the different
repeat types present in the 22qTDR sequence using the
RepeatMasker tool. Using custom perl scripts and blast
analysis, the data was analyzed to extract the location and
name of each type of repeat present in the 22qTDR
sequence and to compare the relationship of each repeat
to the observed SSBR.
Further analysis involved identification of any association
between the SSBR sequence and the sequences around the
boundary of the published deleted regions (PDR) (Table
1). For this, a number of custom tracks were developed in
.bed file format to individually load the following infor-
mation in the IGB (Integrated Genome Browser) [31]: 1.
LCRs located in the 22qTDR based on the chromosome
22 LCR positions as described in [32]; 2. Locations of
SSBRs along the 22qTDR; 3. Locations of different repeat
elements; 4. Approximate boundaries of the PDR as esti-
mated from the locations of the genetic markers. These
tracks were loaded into the IGB along with the annotation
for chromosome 22. This identified a number of occur-
rences of SSBR sequence within each 50 kb block of 250–
300 kb region on both the 5' and 3' ends of the approxi-
mate breakpoint position of the PDR.
Data analysis was facilitated by the use of three different
custom perl script parsers (available upon request): a)
bl2seq_parser.pl: to parse the output of the blast align-
ment tool; b) rmasked_to_bed.pl: to parse the output of
the RepeatMasker tool to extract the location and identity
of repeat elements and to convert the results in .bed file
format so that they can be loaded to UCSC [33] or IGB
genome browser; c) BedAnalyzer.pl: to parse repeat ele-
ment data file for possible occurrence of SSBR sequence in
different repeat families.
Results
Clinical characteristics of the patient
This male patient was born to non-consanguineous par-
ents at normal gestation weighing 6 pounds. Pregnancy
was uncomplicated with no exposure to known tera-
togens and delivery was by caesarean section. In early
infancy, the patient suffered frequent nasopharyngeal
reflux, and speech delay was evident by 3 years of age. Vel-
opharyngeal insufficiency and a submucous cleft palate
were identified by nasal endoscopy and as a result the
patient underwent pharyngoplasty. Carotid arteries were
noted to be medially deviated, however a 2D echocardio-
gram showed no evidence of a congenital heart defect. His
serum calcium levels have been borderline low. At age 18,
this individual showed minimal facial expression, had a
head circumference at 90th percentile, a weight greater
than 98th percentile and a height at 75th percentile. Palpe-
bral fissures were normal in length measuring 3.0 cm
(90th percentile). Palate was abnormal with the pharyn-
geal flap evident. The patient had limited flexion of the
thumbs, and deep tendon reflexes were very brisk with
unsustained ankle clonus. Academically, he completed a
basic level secondary school education and socially
tended to be introverted. His mother's chromosome
results using the 22q FISH probe were normal. The
patient's father was not available for testing.
Deletion analysis
We performed molecular characterization of the deletion
in order to precisely define the interval encompassing the
proximal and distal breakpoints responsible for the
abnormality. The experimental approach relied on quan-
titative PCR using a set of 40 unique primers [see Addi-
tional file 1] to interrogate the 22q11 region at various
intervals starting from the marker WI307 at the proximal
end to D22S936 at the distal end. Following amplifica-
tion, the PCR products were run on a 6% polyacrylamide
gel and specific fragments were quantified. The multiplex
PCR for a given marker included an internal control,
which allowed measurement of the integrated density of
marker-specific PCR products at different cycles. The ratio
of the DNA of target band over control fragment was cal-
culated for the patient and compared to the normal con-
trol. Figure 1 shows an example of the quantitative PCR
analysis which identified the presence of deleted markers
with a 2:1 (Figure 1A) and a non-deleted marker with 1:1
ratio (Figure 1B) of control to patient. Such results on all
markers identified the proximal and the distal break-
Table 1: Approximate breakpoint positions (based on the known/reported marker positions) of previously established deleted regions 
on 22q11 region.
ID Proximal Breakpoint Distal Breakpoint Reference
BM-41/308/293 17063468 20207821 Carlson et al 1997
BM-14 17063468 18725000 Carlson et al 1997
BM-8 17383947 18725000 Carlson et al 1997
G 17579237 19600433 Carlson et al 1997
2.3 Mb Deletion 17001842 19356929 Current StudyBMC Medical Genetics 2006, 7:18 http://www.biomedcentral.com/1471-2350/7/18
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points associated with the patient's deletion (Figure 2) as
explained below.
Proximal breakpoint of 22q11 deletion
Examination of the proximal end of the 22q11 region
assessed markers WI307 to HIRA. The results show that
markers WI307, D22S427 and RH48663 are not deleted
while markers RH48348, G18185, NIB1910, A00IT42,
Cit-trans-11R, D22S609 and HIRA are deleted in this
patient. These results allowed us to map the proximal
breakpoint between the markers RH48663 and RH48348.
Custom primers were designed at regular intervals
between RH48663 and RH48348, and semi-quantitative
PCR analysis situated the proximal breakpoint between
primers P15565 and P15567 (Figure 2). The sequence
between these two primers, designated as the proximal
shortest region of the breakpoint origin (SRBO), is 1750
bp long.
Distal breakpoint of 22q11 deletion
Initial analysis at the distal part of the 22q11 region was
conducted targeting the 9 known genetic markers between
D22S944 to D22S936. Semi-quantitative PCR results
placed the distal breakpoint between the genetic markers
D22S1138 and SHGC-145314, located approximately 80
kb apart in the 22q11 region. Therefore, a more precise
mapping of the distal breakpoint was attempted using a
new set of custom primers that interrogated the 80 kb
region at regular intervals. Our results determined that the
distal breakpoint was located between P17731 and
P177318 (Figure 2). The distance between these two
markers was estimated to be 1172 bp and was designated
as the distal SRBO.
The nature of deletion
The presence of D22S936 and D22S636 in two copies in
this patient indicated that the distal breakpoint lay in the
distal region of the common 3 Mb TDR. Further, the map-
ping of deleted markers including D22S264 suggested
that the size of the deletion was larger than 1.5 Mb yet less
than 3 Mb since the distal breakpoint was flanked by
D22S1138 and SHGC-145314. This information indi-
cated that the hemizygous deletion in this patient was
approximately 2.3 Mb. This novel deletion (approxi-
mately 17001842 – 19356929) contains ~75 genes and
overlaps the 3 Mb deletion common to this genomic area.
Semi-quantitative PCR analysis of the markers at the proximal and distal breakpoint region of 22q11 Figure 1
Semi-quantitative PCR analysis of the markers at the proximal and distal breakpoint region of 22q11. Genetic markers 
D22S1138 (A) and SHGC-145314 (B) were used against control marker CF (cystic fibrosis). The result showed a control-to-
patient intensity ratio of 2:1 and 1:1 respectively. N means normal control and P means patient.
SHGC-145314
 340 bp
Control CF
  98 bp
   B
A
2N:1P
1N:1P
D22S1138
161 bp 
Control CF
  98 bp 
            N         P         N        P         N        P        
22 25 28
              N         P       N        P         N        P        
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The proximal breakpoint of this deletion is localized in
the LCR region common to most reported deletions, but
the distal breakpoint represents a novel site. Next, we
aimed to identify the sequence composition of the two
SRBOs and the novel sequence of the derived chromo-
some. The results of sequencing of the proximal (1750
bp) and distal (1172 bp) SRBOs showed considerable
sequence identity. Specifically, a 90% similar 270 bp
shared sequence between the breakpoint regions (SSBR)
was found to be present. The sequencing of the deletion-
derived chromosome supported the presence of the
shared sequence and yielded a continuous sequence that
was a recombination of the proximal and distal frag-
ments.
Breakpoint sequence and origin analysis
Characterization of SSBR
Extensive blast analysis was performed using the SSBR
sequence in both 22qTDR sequence and its repeat ele-
ment data. When SSBR sequence was compared with the
repeat-masked 22qTDR, the SSBR sequence was masked
and not identified in the commonly deleted region. How-
ever, the SSBR generated a large number of hits with the
non-RepeatMasked 22qTDR sequence. Such results sug-
gest that the SSBR identified in this research belongs to a
family of repeat elements and similar sequences were
identified at 342 locations with >90% identity. Six of
these matches were contained in the proximal SRBO,
located in a region between RH48663 and RH48348 and
8 such matches were located in the distal SRBO between
D22S1138 and SHGC-145314.
Further, we explored the origin of the SSBR sequence by
comparing it with different repeat elements. When the
SSBR was compared with different repeat sequences con-
sidering a minimum alignment length of 200, the SSBR
aligned with SINE/Alu elements 91% of the time and only
7% and 2% of time with LINE/L1 (LINE-1) and LTR (long
terminal repeats)/MaLR (mammalian apparent LTR-retro-
transposon) sequences respectively (Table 2). The SSBR
Genetic markers (filled circle) along the chromosome 22q11 region Figure 2
Genetic markers (filled circle) along the chromosome 22q11 region. The 3 Mb and 1.5 Mb typical deletions are marked above 
the chromosome. Below it are the approximate positions of known genetic and custom primers that were used to interrogate 
the current novel deletion. Proximal and distal SRBOs, along with the approximate breakpoint positions are also shown.BMC Medical Genetics 2006, 7:18 http://www.biomedcentral.com/1471-2350/7/18
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sequence did not show any similarity to other simple or
medium reiteration sequence (MER) type repeats. Such
results imply that this sequence has its origin in the SINE/
Alu group of sequences.
Relationship of SSBR with PDR breakpoints
Integrated Genome Browser allows comparative visualiza-
tion of sequence annotation side by side organized in
tracks. These annotations can be viewed at the nucleotide
level. Chromosome 22 Refseq annotation (H. sapiens May
2004 build data) [34], LCR locations, SSBR alignment to
the 22qTDR, repeat elements and PDR breakpoints data
were loaded as individual tracks into the IGB [see Addi-
tional file 2]. A comparative analysis was performed to
identify the occurrence of SSBRs within the 22qTDR in
relation to previously known breakpoints. The majority of
the PDR breakpoints lie in or near the center of the SSBR
cluster on 22qTDR (Figure 3). The proximal SRBO is
located just 5' of the typical 3 Mb deletion and, along with
the proximal BM41 (Table 1) breakpoint, is situated in the
middle of a SSBR cluster (Figure 3a). For example, the
SSBR nearest to the proximal BM41 is only 108 bp from
the 3' breakpoint and 3 kb from the 5' breakpoint. The
distal SRBO is located between the classical 1.5 and 3 Mb
deletion. Interestingly, the distal BM41, proximal G and
distal G (Table 1) breakpoints are harbored in the center
of SSBR clusters (Figure 3a and 3b). The closest SSBR is
only 294 bp 3' and 385 bp 5' to the distal BM41 break-
point, 416 bp 3' to the distal G breakpoint and 161 bp 3'
to the proximal G breakpoint. The proximal BM8 and dis-
tal BM8/14 breakpoints are located just 3' and 5' to SSBR
clusters (Figure 3c). The nearest SSBR sequence is 2 kb 3'
of the distal BM8/14 breakpoint and only 9 kb from the
proximal BM8 breakpoint. Presence of the SSBR sequence
in multiple copies near all breakpoints suggests that it
may confer susceptibility to chromosomal rearrange-
ments and help to explain the high frequency of deletions
associated with the 22q11 region.
Discussion
The 22q11 region continues to attract genetic interest by
virtue of its involvement in common microdeletions (e.g.
deletion in 22q11), presence of unusual repeats, and as
the potential site responsible for a number of syndromes
and diseases. Of particular interest is the molecular basis
of breakpoints that occur with a biased distribution across
the genome. In this context, a number of LCRs, a prevalent
feature of this region, have been implicated in microdele-
tions [15-19]. It is also clear that not all LCRs are equally
involved in deletions. Although most known deletions
share a common proximal breakpoint, the distal break-
points are not always the same resulting in a deletion
ranging from 3.0 Mb (the most common) to 1.5 Mb in
size. Recently, a number of rare deletions of intermediate
size (2.8 Mb) have also been reported [35]. This report
describes another such case with a deletion size of 2.3 Mb.
Detailed sequencing of the breakpoints, included in this
report, has allowed identification of an SSBR with poten-
tial to undergo intra-chromosomal pairing and recombi-
nation causing this novel 2.3 Mb. deletion. The
significance of such SSBRs potentially located at other
breakpoints is discussed below.
Defining breakpoints in a 22q11 deletion
Molecular characterization of the deletion in this patient
utilized a total of 40 markers distributed across the 22q11
region using semi-quantitative PCR and was found to be
highly effective and reliable. Mapping of the deleted and
non-deleted markers on the chromosomal sequence
placed the proximal breakpoint site at 17001842 bp and
the distal site at 19356929 bp (Table 1). This represents a
novel deletion of 2.3 Mb length and is contained within
the most common 3.0 Mb TDR (Figure 2) [36]. The prox-
imal breakpoint matches with other reported deletions in
the LCR region, but the distal breakpoint represents a new
breakpoint site that does not correspond to known LCRs
of 22q11. Interestingly, the two breakpoint regions of this
Table 2: Alignment of SSBR sequence with different repeat elements.
Sequence length 
interval
SINE/Alu LINE Simple repeats DNA/MER1_type LTR/MALR
2 7 0 – 2 7 9 7 2 7001
260–269 70 0 0 0
2 5 0 – 2 5 9 3 2 1001
2 4 0 – 2 4 9 41001
230–239 10 3 0 0
2 2 0 – 2 2 9 4100
2 1 0 – 2 1 9 20001
2 0 0 – 2 0 9 42001
T o t a l 1 9 8 1 5 005BMC Medical Genetics 2006, 7:18 http://www.biomedcentral.com/1471-2350/7/18
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patient share a short 270 bp SSBR sequence with >90%
similarity. We have hypothesized that this sequence may
facilitate intra-chromosomal pairing and cross-over
resulting in a 2.3 Mb deletion in the gamete of one of the
parents. Our SSBR sequence shares extensive sequence
similarity with SINE/Alu as well as some similarity with
LINE and LTR/MaLR sequence. The predicted origin of
this sequence appears to involve the common repeats of
the human genome and is embedded in the LCRs of the
chromosome 22.
Origin and mechanism of the 2.3 Mb 22q11 deletion
We propose that the mechanism of this novel deletion is
not any different from other deletions of this region, even
though its distal breakpoint was not contained in an LCR
area. This may be due to the fact that the two breakpoints
share enough sequence similarity to SINE/Alu elements to
facilitate chromosomal rearrangement (Figure 4). This
model was based on the generic homologous recombina-
tion mechanism proposed earlier [22,37]. Extensive simi-
larity of the SSBRs to Alu elements is also backed by the
Relationship between SSBR occurrence and approximate PDR breakpoint positions on 22qTDR Figure 3
Relationship between SSBR occurrence and approximate PDR breakpoint positions on 22qTDR. The x-axis marks/represents 
the interval on the 22qTDR in 250-200 Kb regions on both the 5' and 3' end of the PDR breakpoint (marked in the center by a 
vertical line). Y-axis displays the number of SSBRs present in each 50 Kb interval on x-axis.
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fact that Alu elements are also approximately 280 bp in
length [24] and different subfamilies of Alu elements have
formed and become mobilized at different times in the
evolution of primate species [38].
The role of SINE/Alu repeats in modulating the architec-
ture of the human genome in association with human dis-
orders and in mediating gene rearrangements has also
been established [25,26]. The most frequent mechanisms
by which Alu elements modulate architecture are transpo-
sition and unequal homologous recombination, both of
which have been linked to human diseases [26]. Babcock
et al., 2003, [32] have shown that Alu-mediated rearrange-
ments are responsible for shaping the genes within
LCR22s and found evidence of unequal crossover mecha-
nisms between Alu elements that are likely responsible for
the rearrangements. Homology between Alu elements
may be responsible for misalignment of chromosomes
during meiosis. Interestingly, the majority of human
genetic disorders caused by homologous recombination
between repetitive sequence are the result of Alu-Alu
recombination [25,26,39]. Thus, it is highly likely that the
two SRBO regions will have the potential to pair intra-
chromosomally through Alu like SSBR sequence. Further,
a crossover between the SRBO by SSBR may have gener-
ated this 2.3 Mb deletion in this patient.
Besides Alu, SSBR-like sequence mediated crossover
mechanisms have been reported for a number of dele-
tions in the human genome. For example, in the case of
hereditary neuropathy with liability to pressure palsies
(HNPP, OMIM 162500) [40], VCFS [41,42] and in ADU
breakpoint [20] with a sequence size range of 550 to 750
bp. The presence of the SSBR sequence in the proximal
and distal SRBOs suggests a similar rearrangement (Figure
4) in the 22qTDR, resulting in a 2.3 Mb deletion in this
patient. The mechanism proposed also appears to be com-
mon for deletions in humans at a number of sites in the
human genome. These include the 7q11.23 region
involved in Williams syndrome [43], 17p11.2 involved in
Smith-Magenis syndrome [44] and 15q11-13 involved in
Prader-Willi syndrome [45], among others. Also, the pres-
ence of SSBR in multiple copies around the SRBO indi-
cates that the SSBR sequence is particularly susceptible to
genome rearrangement by homologous recombination.
Identification of the SSBRs associated with most such
deletions will be valuable in refining this generic model to
include sequence specificity, as identified in this report.
Conclusion
This research has identified a novel 2.3 Mb deletion in the
22q11 region. Analysis of the sequence at the breakpoints
revealed a SSBR that showed strong sequence similarity to
SINE/Alu elements. This Alu like SSBR sequence fragment
is distributed across the 22qTDR with a higher frequency
in the previously known breakpoint regions. Evidence
provided above suggests that, this SSBR may be involved
in the mispairing of the SRBOs or LCRs during homolo-
gous recombination resulting in chromosomal rearrange-
ment leading to deletion in the 22q11 region.
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Model for intra-chromosomal rearrangement/recombination  between SSBR sequences leading to deletion in chromosome  22 Figure 4
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